REMICADE® 100mg vial (Non-English)

Manufacturer: Janssen Biotech
Active Substance(s): INFLIXIMAB
Strength: 100mg
Pack Size: 1 x 100mg Vial

REMICADE is a prescription medicine that is approved for patients with:
• Rheumatoid Arthritis – adults with moderately to severely active rheumatoid arthritis, along with the medicine methotrexate.
• Crohn’s Disease – children 6 years and older and adults with Crohn’s disease who have not responded well to other medicines.
• Ankylosing Spondylitis in adults
• Psoriatic Arthritis in adults
• Plaque Psoriasis – adult patients with plaque psoriasis that is chronic (does not go away), severe, extensive, and/or disabling.
• Ulcerative Colitis – children 6 years and older and adults with moderately to severely active ulcerative colitis who have not
responded well to other medicines.
REMICADE blocks the action of a protein in your body called tumor necrosis factor-alpha (TNF-alpha). TNF-alpha is made by your
body’s immune system. People with certain diseases have too much TNF-alpha that can cause the immune system to attack normal
healthy parts of the body. REMICADE can block the damage caused by too much TNF-alpha.